Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Treasury Shares: 2022-2024

Historic Treasury Shares for Amylyx Pharmaceuticals (AMLX) over the last 3 years, with Dec 2024 value amounting to $2.2 million.

  • Amylyx Pharmaceuticals' Treasury Shares rose 21.65% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 21.65%. This contributed to the annual value of $2.2 million for FY2024, which is 98.91% up from last year.
  • According to the latest figures from FY2024, Amylyx Pharmaceuticals' Treasury Shares is $2.2 million, which was up 98.91% from $1.1 million recorded in FY2023.
  • Amylyx Pharmaceuticals' Treasury Shares' 5-year high stood at $2.2 million during FY2024, with a 5-year trough of $740,297 in FY2022.
  • Moreover, its 3-year median value for Treasury Shares was $1.1 million (2023), whereas its average is $1.4 million.
  • Data for Amylyx Pharmaceuticals' Treasury Shares shows a peak YoY skyrocketed of 98.91% (in 2024) over the last 5 years.
  • Over the past 3 years, Amylyx Pharmaceuticals' Treasury Shares (Yearly) stood at $740,297 in 2022, then soared by 50.28% to $1.1 million in 2023, then soared by 98.91% to $2.2 million in 2024.